This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_STOMACH_NEUROENDOCRINE_EXALLC for full statistics.
Neuroendocrine tumor and carcinoma of stomach
C3_STOMACH_NEUROENDOCRINE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
C16
Cancer registry: Morphology ICD-O-3
8240|824[2-4]|8246|8249
Cancer registry: Behaviour codes
3
1 out of 7 registries used, show all original rules.
114
Check minimum number of events None
114
Include endpoints None
114
Remove individuals based on genotype QC
111
C3_STOMACH_NEUROENDOCRINE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of stomach
based on the number of shared cases.
Broader endpoints:
- Neuroendocrine tumor and carcinoma of stomach (controls excluding all cancers)
- Malignant neoplasm of stomach (controls excluding all cancers)
- Malignant neoplasm of stomach
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 111 | 61 | 50 |
| Unadjusted prevalence (%) | 0.03 | 0.03 | 0.03 |
| Mean age at first event (years) | 59.52 | 56.66 | 63.00 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_STOMACH_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of stomach
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Neuroendocrine tumor and carcinoma of stomach
↥Endpoint not on priority list, no data to show.